HCA
HCA Healthcare, Inc.
NYSE · Healthcare · Medical - Care Facilities · US
$406.46
−0.67%Year over year
Reported trailing growth
- Revenue
- +7.3%
- EBITDA
- +10.3%
- EBIT
- +9.0%
- EPS
- +24.5%
- Free cash flow
- -17.8%
- Operating cash flow
- -6.8%
Forward estimates
Based on analyst estimates
- Revenue
- +2.2%
- EBITDA
- +3.0%
- EPS
- +2.2%
Three-year CAGR
- Revenue
- +7.9%
- EBITDA
- +5.5%
- EBIT
- +9.7%
- Net income
- +6.3%
- EPS
- +13.8%
- Free cash flow
- +23.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026